Evaluation of New Histoprognostic Criteria in a Retrospective Study of Colon Cancers Operated at Amiens University Hospital

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02942862

Enrollment

231

Registered

2016-10-24

Start date

2015-02-28

Completion date

2015-04-30

Last updated

2016-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Neoplasms

Brief summary

Colon cancer is a very common cancer. Prognosis and adjuvant treatment depend on the pathological results. Histoprognostic new factors have recently been published by several authors, but their validity is still debated.

Interventions

DRUGOrcein staining

Prognostic value of venous emboli detected by orcein staining

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients operated on for colon adenocarcinoma between 2004 and 2009 at the University Hospital of Amiens

Exclusion criteria

* Non-operated patients * Patients operated on before 2004 or after 2009 * Patients operated in another center * The other histological types * Vicinity of tumors invading the colon by contiguity * Colic metastasis * Patients whose blocks or blades were not found in the archives.

Design outcomes

Primary

Measure	Time frame
survival	1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026